Abstract:Poly- and perfluoroalkyl substances (PFASs), especially perfluoroalkyl acids (PFAAs), have garnered broad attention due to their near ubiquitous presence in environmental and biological matrices, recalcitrant nature, and reported negative human health impacts. Processes using high-pressure membranes such as reverse osmosis (RO) and nanofiltration (NF) have been investigated as PFAA treatment technologies due to their ability to separate dissolved solutes such as inorganic ions, and small molecular weight organic compounds. The major drawback associated with high-pressure membranes is management of the concentrate stream produced during treatment. As a result, high recovery membrane system configurations have been developed with the goal of minimizing volume of concentrate requiring disposal. In the context of PFAS treatment, high-recovery membrane applications may be beneficial; PFAS residuals could be concentrated allowing advantages in terms of disposal, e.g., more effective application of PFAS destruction technologies. The objective of this study was to evaluate the PFAA rejection performance of commercially available high-pressure membranes in a pilot-scale closed-circuit membrane filtration (CCMF) system. The rejection of nine PFAAs by four spiral wound membrane products spanning characteristics ranging from loose NF to seawater RO was investigated during and through two closed-circuit sequences each operating up to 97% recovery. Mechanisms of PFAA rejection including steric and electrostatic exclusion were investigated through analysis of generated data, and ionic strength experiments. Additionally, short-term foulant accumulation during CCMF and normalized energy analysis were performed by monitoring the calculated temperature corrected specific flux (TCSF) and design software simulations, respectively. Results from this study demonstrate that tight NF and RO membranes are effective for separating and concentrating PFAAs during high recovery CCMF operation. During CCMF sequences to 97% water recovery, the NF90, CR100, and SW30 membranes evaluated exhibited overall rejection values of > 98.3% for the PFAAs quantified in this study. The loose NF membrane element investigated (NF270) exhibited the lowest PFAA rejection performance during the high recovery experiments, particularly at water recoveries > 90%. Diminished PFAA rejection performance of the NF270 is likely a result of both steric and electrostatic exclusion being significant separation mechanisms. Feed water amended with sodium sulfate yielded lower rejection for PFAAs by the NF270 compared to unamended feed water supporting the hypothesis that that high recovery CCMF operation may negatively impact PFAS rejection by loose NF membranes, particularly membranes that rely on electrostatic exclusion for separation of anions.

Rejection of pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) by low pressure reverse osmosis membranes

Elucidating the Rejection Mechanisms of PPCPs by Nanofiltration and Reverse Osmosis Membranes

Typical Pharmaceutical Molecule Removal Behavior from Water by Positively and Negatively Charged Composite Hollow Fiber Nanofiltration Membranes.

Rejection mechanisms for contaminants in polymeric reverse osmosis membranes

Rejection of emerging organic micropollutants in nanofiltration-reverse osmosis membrane applications

Role of Membrane and Compound Properties in Affecting the Rejection of Pharmaceuticals by Different RO/NF Membranes

Atomistic Simulations of Biofouling and Molecular Transfer of a Cross-linked Aromatic Polyamide Membrane for Desalination

Does Hydrophilic Polydopamine Coating Enhance Membrane Rejection of Hydrophobic Endocrine-Disrupting Compounds?

Quantifying the Influence of Solute-Membrane Interactions on Adsorption and Rejection of Pharmaceuticals by NF/RO Membranes

Removal of antibiotics and estrogens by nanofiltration and reverse osmosis membranes

4-Dimethylaminopyridine promoted interfacial polymerization between hyperbranched polyesteramide and trimesoyl chloride for preparing ultralow-pressure reverse osmosis composite membrane.

Removal of Pharmaceutical and Personal Care Products from Reverse Osmosis Retentate Using Advanced Oxidation Processes

Rejection of pharmaceuticals during forward osmosis and prediction by using the solution–diffusion model

Comparison of polyamide nanofiltration and low-pressure reverse osmosis membranes on As(III) rejection under various operational conditions

Rejection of perfluoroalkyl acids by nanofiltration and reverse osmosis in a high-recovery closed-circuit membrane filtration system

Evaluation of commercial nanofiltration and reverse osmosis membrane filtration to remove per‐and polyfluoroalkyl substances (PFAS): Effects of transmembrane pressures and water matrices

Removal of Typical PPCPs by Reverse Osmosis Membranes: Optimization of Treatment Process by Factorial Design

Removal of pharmaceuticals and personal care products (PPCPs) and environmental estrogens (EEs) from water using positively charged hollow fiber nanofiltration membrane

Surface room-temperature treatment of polyamide-based reverse osmosis membrane by diazotization reagent: Perm-selectivity regulation and mechanism

Effects of surfactants, ion valency and solution temperature on PFAS rejection in commercial reverse osmosis (RO) and nanofiltration (NF) processes

Achieving overall rejection of pharmaceuticals and personal care products of different polarities by controlling interlayer charging environment of graphene oxide membrane using carbon quantum dots